Results 251 to 260 of about 261,516 (285)
Non-HDL-cholesterol in an adolescent diabetes population
Screening for dyslipidemia poses some challenges. Nonfasting lipid profiles frequently have elevated triglycerides. In addition, in the standard lipid profile, low-density lipoprotein (LDL) cholesterol is a calculated value rather than a direct measurement and is triglyceride dependent.
Ranita E, Kuryan +2 more
openaire +3 more sources
Purpose of review Non-HDL cholesterol was originally conceived as a therapeutic target for statin treatment in hypertriglyceridaemia when apolipoprotein B100 assays were not widely available. Recently non-HDL cholesterol has been recommended to replace LDL cholesterol in the clinical management of dyslipidaemia routinely in ...
Soran, Handrean +3 more
openaire +3 more sources
HDL-cholesterol (HDL-C) and non-HDL-cholesterol (nHDL-C) are involved in atherosclerosis. The aim of this study was to determine the distribution of HDL-C and nHDL-C and its association with cardiovascular and socio-cultural variables in a pediatric Brazilian sample.Children and adolescents from Florianopolis were randomly selected and a structured ...
I, Giuliano +5 more
openaire +3 more sources
Aims: The total cholesterol (TC)/high-density lipoprotein (HDL) cholesterol ratio may carry additional information not available in more commonly used single cholesterol measures.
Renato Quispe +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Non-HDL cholesterol and apoB in dyslipidaemia
Clinical Science, 2007On the basis of a high correlation, non-HDL-C (non-high-density lipoprotein cholesterol) and apoB (apolipoprotein B) have been suggested to be of equivalent value for clinical practice; however, the strength of this relationship has not been examined in detail in patients with dyslipidaemia. The present study examines the variance of non-HDL-C compared
Allan D, Sniderman +4 more
openaire +2 more sources
Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
Current Pharmaceutical Design, 2014Maintaining total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels within healthy limits decreases the risk of atherosclerotic vascular disease (AVD) and cardiovascular (CV) events. The predictive value of elevated TG levels for coronary artery disease (CAD) seen in
STEFANUTTI, Claudia +2 more
openaire +3 more sources
Non-HDL Cholesterol, Obesity, and Metabolic Syndrome in Epileptic Patients
The Primary Care Companion For CNS Disorders, 2022Objective: To compare cardiovascular risk factors in patients with epilepsy with those of non-epileptic neurologic patients to determine their association with antiepileptic drug therapy.Methods: This observational study with a cross-sectional design was performed in a tertiary care hospital in the Eastern Province of Saudi Arabia from January to ...
Inam E, Khuda +5 more
openaire +2 more sources
Determination of Non-HDL Cholesterol in Diabetic and Hypertensive Patients
American Journal of Therapeutics, 2010Recently, it has been suggested that non-high-density lipoprotein (non-HDL) cholesterol measure is a useful evaluation tool to assess heart disease death risk. The non-HDL cholesterol is defined as the value between total cholesterol and HDL - total cholesterol, and it involves the different fractions of lipoproteins: low-density lipoprotein ...
Freddy, Contreras +8 more
openaire +2 more sources
The importance of non–HDL cholesterol reporting in lipid management
Journal of Clinical Lipidology, 2008Plasma levels of lipids and lipoproteins are essential to the management of lipid disorders by generalists and by practitioners of the emerging specialty of clinical lipidology. The routine lipid panel consists of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides.
Michael J, Blaha +3 more
openaire +2 more sources
Targeting Residual Risk: The Rationale for the Use of Non-HDL Cholesterol
Southern Medical Journal, 2010There is a wealth of epidemiological and clinical data linking low-density lipoprotein cholesterol (LDLc) with atherosclerotic cardiovascular disease. Numerous primary and secondary prevention trials have demonstrated that reduction in LDLc leads to significant decrease in cardiovascular event rates. However, patients continue to be at significant risk
Venkata M, Alla +2 more
openaire +2 more sources

